Company / Operating Margin
10x Genomics, Inc. Operating Margin History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-9.5%
FY2025
5-year range
-42.9% / -9.5%
FY2021-FY2025
Trend
+70.2%
vs FY2024
Sector context
#114 of 143
Health Care
What the data says
10x Genomics, Inc.'s operating margin of -9.5% is lower than 80% of companies in the Health Care sector (FY2025). Operating Margin has fluctuated over the past 9 years, ranging from -178.7% in FY2020 to -9.5% in FY2025.
Based on SEC 10-K filings.
-9.5% in FY2025 with a 5-year CAGR of +169.3%.
Improved from -42.9% to -9.5% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +23.0pp
- 5-Year Change
- +169.3pp
- 10-Year Change
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 143This company -9.5% Sector average -295.2%
▼
+96.8% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 70.2% year-over-year.
- Currently 285.7pp above the Health Care sector average.
- Lowest operating margin in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -9.5% | +70.2% |
| FY2024 | -31.9% | +25.7% |
| FY2023 | -42.9% | -31.9% |
| FY2022 | -32.5% | -205.4% |
| FY2021 | -10.7% | +94.0% |
| FY2020 | -178.7% | -213.2% |
| FY2019 | -57.1% | +24.6% |
| FY2018 | -75.7% | -192.9% |
| FY2017 | -25.8% | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026